Overview

Join us for an exclusive, one-of-a-kind summit featuring updates on breakthroughs in research and treatment in the cell therapies space. Global thought leaders will share their perspectives on the current and future state of the liquid and solid tumor cell therapy landscape.

Learning Objectives

• Critically evaluate the current landscape of cell therapy in hematologic malignancies, analyzing the latest clinical trial outcomes and evidence-based practices.
• Explore innovative strategies and emerging technologies in cell therapy for solid tumors and hematologic malignancies, focusing on the development and application of novel cellular treatments.
• Foster interdisciplinary collaboration between community oncologists, cell therapists, clinical investigators, and solid tumor disease experts, in order to increase access and accelerate translation of CAR-T, TIL, and other transformative cell therapies.

Target Audience

The event is open to anyone interested in learning more about the current and future states of cell therapy treatments. Providers, researchers, and industry leaders are encouraged to attend.

For more information please visit the official event page.